BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30

• Drug Development

  DBV Tech Announces Publication Of Preclinical Data In JACI Suggesting EPIT Provides Sustained Protection Against Anaphylaxis

  June 13, 2016

   · 

  3 min read
• Mallinckrodt Submits Investigational New Drug Application For Synacthen Depot

  June 13, 2016

   · 

  4 min read
• Policy

  Percussionaire Corporation, Adel Bougatef, MD Phd, And Marleen De Heyn Reach Amicable Settlement Resolution

  June 13, 2016

   · 

  1 min read
• Business

  Bay Area’s NovaBay Names Mark Sieczkarek as Permanent CEO

  June 13, 2016

   · 

  4 min read
• Deals

  Bay Area’s Viveve Plans to Raise $13 Million in IPO

  June 13, 2016

   · 

  1 min read
• Job Trends

  SurModics to Create 100 New Jobs in Ireland

  June 13, 2016

   · 

  1 min read
• Drug Development

  Galena Biopharma Receives Two Orphan Drug Designations For GALE-301 And GALE-301/GALE-302

  June 13, 2016

   · 

  5 min read
• Drug Development

  uniQure Presents Clinical Data From Ongoing Phase I/II Study In Hemophilia B Demonstrating 6 Months Of Sustained Increases In Factor IX Activity

  June 13, 2016

   · 

  9 min read
• Drug Development

  Zafgen Presents New Data From The Phase IIb Clinical Trial Evaluating Beloranib In Severe Obesity Complicated By Type 2 Diabetes At The American Diabetes Association’s 76th Scientific Sessions

  June 13, 2016

   · 

  11 min read
• Drug Development

  SymBio Pharma Release: Initiation Of Phase III Clinical Trial On The Patient-Controlled Pain Management Drug “SyB P-1501"

  June 13, 2016

   · 

  1 min read